Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Svensson, Maria K ^a   Lindmark, Stina ^b   Wiklund, Urban ^b   Rask, Peter ^c   Karlsson, Marcus ^b   Myrin, Jan ^c   Kullberg, Joel ^a   Johansson, Lars ^a   Eriksson, Jan W ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autonomic nervous system; Heart rate variability; Insulin sensitivity; Spectral analysis; Type 2 diabetes

Indexed keywords

INSULIN; GLUCOSE BLOOD LEVEL;

ABDOMINAL FAT; ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARASYMPATHETIC NERVE; POWER SPECTRUM; SYMPATHETIC NERVE; AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART RATE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 84975818447     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0411-8     Document Type: Article

References (39)

1. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989;321:337-43.
2. Vestergaard H, Bjorbaek C, Andersen PH, Bak JF, Pedersen O. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes. 1991;40:1740-5.
3. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:1714-21.
4. Zierath JR, Galuska D, Nolte LA, Thorne A, Kristensen JS, Wallberg-Henriksson H. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia. 1994;37:270-7.
5. Buren J, Lindmark S, Renstrom F, Eriksson JW. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism. 2003;52:239-45.
6. Huggett RJ, Hogarth AJ, Mackintosh AF, Mary DA. Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetologia. 2006;49:2741-4.
7. Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res. 2015;2015:341583.
8. Lindmark S, Lonn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes Res. 2005;13:717-28.
9. Laitinen T, Vauhkonen IK, Niskanen LK, et al. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes. 1999;48:1295-9.
10. Saito I, Hitsumoto S, Maruyama K, et al. Heart rate variability, insulin resistance, and insulin sensitivity in Japanese adults: The Toon Health Study. J Epidemiol. 2015;25:583-91.
11. Stuckey MI, Kiviniemi A, Gill DP, Shoemaker JK, Petrella RJ. Associations between heart rate variability, metabolic syndrome risk factors, and insulin resistance. Appl Physiol Nutr Metab. 2015;40:734-40.
12. Wulsin LR, Horn PS, Perry JL, Massaro J, D'Agostino R. Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality autonomic imbalance predicts CVD, DM, Mortality. J Clin Endocrinol Metab. jc20144123. 2015.
13. Malliani A, Lombardi F, Pagani M. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J. 1994;71:1-2.
14. Lukaski HC. Validation of body composition assessment techniques in the dialysis population. ASAIO J. 1997;43:251-5.
15. Claesson M, Burell G, Birgander LS, Lindahl B, Asplund K. Psychosocial distress and impaired quality of life-targets neglected in the secondary prevention in women with ischaemic heart disease. Eur J Cardiovasc Prev Rehabil. 2003;10:258-66.
16. Eriksson JW, Jansson PA, Foley K, Lithell H. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients. J Hypertens. 1996;14:1469-75.
17. Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R. A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord. 1994;18:219-34.
18. Rasband WS. ImageJ (version v1.37s). US National Institutes of Health, Bethesda. 2006. http://rsb.info.nih.gov/ij/. Assessed 17 June 2016.
19. DeFronzo R, Deibert D, Hendler R, Felig P, Soman V. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest. 1979;63:939-46.
20. Blom H, Andersson C, Olofsson BO, Bjerle P, Wiklund U, Lithner F. Assessment of autonomic nerve function in acute intermittent porphyria; a study based on spectral analysis of heart rate variability. J Intern Med. 1996;240:73-9.
21. Wiklund U, Hornsten R, Karlsson M, Suhr OB, Jensen SM. Abnormal heart rate variability and subtle atrial arrhythmia in patients with familial amyloidotic polyneuropathy. Ann Noninvasive Electrocardiol. 2008;13:249-56.
22. Karlsson M, Hornsten R, Rydberg A, Wiklund U. Automatic filtering of outliers in RR intervals before analysis of heart rate variability in Holter recordings: a comparison with carefully edited data. Biomed Eng Online. 2012;11:2.
23. Luutonen S, Antila K, Neuvonen P, Raiha I, Rajala T, Sourander L. Spectral analysis of heart rate variability in evaluation of sympathetic function in elderly subjects. Age Ageing. 1994;23:473-7.
24. Lindmark S, Wiklund U, Bjerle P, Eriksson JW. Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of type 2 diabetes patients and control subjects. Diabet Med. 2003;20:399-405.
25. Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, Damsgaard EM. Autonomic neuropathy in nondiabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure: the Fredericia study. Diabetes. 2001;50:630-6.
26. Tripathi KK. Very low frequency oscillations in the power spectra of heart rate variability during dry supine immersion and exposure to non-hypoxic hypobaria. Physiol Meas. 2011;32:717-29.
27. Svensson MK, Jansson PA, Persson AL, Sjostrand M, Eriksson JW. Atropine improves insulin sensitivity in both lean and abdominally obese subjects. J Clin Endocrinol Metab. 2011;96:E1843-7.
28. Ziegler D, Strom A, Nowotny B, et al. Effect of low-energy diets differing in fiber, red meat, and coffee intake on cardiac autonomic function in obese individuals with type 2 diabetes. Diabetes Care. 2015;38:1750-7.
29. Hansen T, Ahlstrom H, Soderberg S, et al. Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population. Atherosclerosis. 2009;205:163-7.
30. Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring). 2010;18:2191-8.
31. Benthem L, Keizer K, Wiegman CH, et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab. 2000;279:E1286-93.
32. Zeng W, Pirzgalska RM, Pereira MM, et al. Sympathetic neuro-adipose connections mediate leptin-driven lipolysis. Cell. 2015;163:84-94.
33. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians. 1999;111:241-8.
34. Saito I, Hitsumoto S, Maruyama K, et al. Impact of heart rate variability on C-reactive protein concentrations in Japanese adult nonsmokers: The Toon Health Study. Atherosclerosis. 2016;244:79-85.
35. Kurajoh M, Koyama H, Kadoya M, et al. Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study. Cardiovasc Diabetol. 2015;14:117.
36. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106:453-8.
37. Licht CM, de Geus EJ, Penninx BW. Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:2484-93.
38. Jiang X, Liu X, Wu S, et al. Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study. Heart. 2015;101:44-9.
39. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354-81.